# TESTOSTERONE
> **ANDA210835** · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2020-04-16
## Drug
- **FDA Application Number:** ANDA210835
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TESTOSTERONE
- **Generic name:** TESTOSTERONE
- **Active ingredients:** TESTOSTERONE
- **Dosage form:** GEL, METERED
- **Route:** TRANSDERMAL
- **Marketing status:** Prescription
- **Sponsor:** XIROMED
- **Manufacturer:** Xiromed, LLC
- **First approval:** 2020-04-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210835)
---
*AI Analytics · CC0 1.0*